MSH|^~\&|LAB|ARH|||201910280955||ORU^R01|4091034|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.1000^CP7^Chem 7 - Glu R,Urea,Crea,Lytes^^^XXX-1710||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|2|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.3800^CA^Calcium^^2000-8^2000-8||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|3|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.3900^MG^Magnesium^^2601-3^2601-3||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|4|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.4000^PHOS^Phosphate^^14879-1^14879-1||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|5|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.4200^LFT^TP,ALB,GGT,AST,ALT,BILT,ALK^^^XXX-1710||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|6|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.5690^TROP^Troponin I^^^10839-9||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|7|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.5800^CK^Creatine Kinase^^2157-6^2157-6||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|8|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|9|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.7020^PCT^Procalcitonin Level^^^33959-8||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|10|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|522.2490^BHCG^Beta-HCG^^^21198-7||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||

MSH|^~\&|LAB|ARH|||201910281003||ORU^R01|4091040|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.1000^CP7^Chem 7 - Glu R,Urea,Crea,Lytes^^^XXX-1710||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|2|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.3800^CA^Calcium^^2000-8^2000-8||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|3|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.3900^MG^Magnesium^^2601-3^2601-3||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|4|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.4000^PHOS^Phosphate^^14879-1^14879-1||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|5|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.4200^LFT^TP,ALB,GGT,AST,ALT,BILT,ALK^^^XXX-1710||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|6|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.5690^TROP^Troponin I^^^10839-9||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|7|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.5800^CK^Creatine Kinase^^2157-6^2157-6||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|8|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|9|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.7020^PCT^Procalcitonin Level^^^33959-8||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|10|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|522.2490^BHCG^Beta-HCG^^^21198-7||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||

MSH|^~\&|LAB|ARH|||201910281020||ORU^R01|4091045|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.1000^CP7^Chem 7 - Glu R,Urea,Crea,Lytes^^^XXX-1710||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.1900^NA^Sodium^^2951-2^2951-2|1|145^^Y|mmol/L|135-145|N||A^S|F|||201910281020
OBX|2|ST|500.2000^K^Potassium^^2823-3^2823-3|1|3.4^^Y|mmol/L|3.5-5.0|L||A^S|F|||201910281020
OBX|3|ST|500.2100^CL^Chloride^^2075-0^2075-0|1|105^^Y|mmol/L|98-108|N||A^S|F|||201910281020
OBX|4|ST|500.2200^BICARB^Bicarbonate^^1962-0^1962-0|1|25^^Y|mmol/L|20-30|N||A^S|F|||201910281020
OBX|5|ST|500.2300^GAP^Anion Gap^^33037-3^33037-3|1|15^^Y|mmol/L|3-16|N||A^S|F|||201910281020
OBX|6|ST|500.2400^UREA^Urea^^14937-7^22664-7|1|8^^Y|mmol/L|2-9|N||A^S|F|||201910281020
OBX|7|ST|500.2600^CR^Creatinine Modified Jaffe^^14682-9^14682-9|1|70^^Y|umol/L|45-90|N||A^S|F|||201910281020
OBX|8|ST|500.2700^EGFR^Glomerular Filtration Rate Est^^33914-3^33914-3|1|88^^Y|mL/min|>60|N||A^S|F|||201910281020
OBX|9|ST|500.2900^GLU^Glucose, Random^^14749-6^14749-6|1|2.0^^Y|mmol/L|3.6-7.8|LL||A^S|F|||201910281020
NTE|1||*CRITICAL VALUE
OBR|2|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.3800^CA^Calcium^^2000-8^2000-8||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.3800^CA^Calcium^^2000-8^2000-8|1|1.00^^Y|mmol/L|2.10-2.60|LL||A^S|F|||201910281020
NTE|1||*CRITICAL VALUE
OBR|3|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.3900^MG^Magnesium^^2601-3^2601-3||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.3900^MG^Magnesium^^2601-3^2601-3|1|1.1^^Y|mmol/L|0.7-1.2|N||A^S|F|||201910281020
OBR|4|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.4000^PHOS^Phosphate^^14879-1^14879-1||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.4000^PHOS^Phosphate^^14879-1^14879-1|1|1.0^^Y|mmol/L|0.8-1.5|N||A^S|F|||201910281020
OBR|5|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.4200^LFT^TP,ALB,GGT,AST,ALT,BILT,ALK^^^XXX-1710||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.4500^PROT^Protein^^2885-2^2885-2|1|90^^Y|g/L|55-80|H||A^S|F|||201910281020
OBX|2|ST|500.4600^ALB^Albumin^^1751-7^61152-5|1|70^^Y|g/L|35-50|H||A^S|F|||201910281020
OBX|3|ST|500.4700^ALK^Alkaline Phosphatase^^6768-6^6768-6|1|200^^Y|U/L|35-105|H||A^S|F|||201910281020
OBX|4|ST|500.4800^GGT^Gamma Glutamyl Transferase^^2324-2^2324-2|1|400^^Y|U/L|<31|H||A^S|F|||201910281020
OBX|5|ST|500.4900^ALT^Alanine Aminotransferase^^1742-6^1744-2|1|70^^Y|U/L|<36|H||A^S|F|||201910281020
OBX|6|ST|500.5000^AST^Aspartate Aminotransferase^^1920-8^1920-8|1|35^^Y|U/L|<36|N||A^S|F|||201910281020
OBX|7|ST|500.5200^BILT^Bilirubin, Total^^14631-6^14631-6|1|50^^Y|umol/L|2-17|H||A^S|F|||201910281020
OBR|6|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.5690^TROP^Troponin I^^^10839-9||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.5695^TROPIHS^Troponin I High Sensitivity^^89579-7^89579-7|1|5^^Y|ng/L|<18|N||A^S|F|||201910281020
NTE|1||Detectable Troponin I present. To assess the risk of acute
NTE|2||myocardial injury, consider repeat Troponin I in 3 hours to
NTE|3||evaluate the change ("delta"). If this is a follow up
NTE|4||Troponin I collected within 3-6 hours of previous:
NTE|5||Delta < 11 ng/L: Acute myocardial injury is unlikely.
NTE|6||Delta 11 - 21 ng/L: Consistent with myocardial injury, but
NTE|7||low positive predictive value for an acute event. Consider a
NTE|8||further Troponin I in another 3 hours to re-evaluate.
NTE|9||Delta >= 22 ng/L: Critical change in Troponin I. Result is
NTE|10||highly predictive for acute myocardial injury.
OBR|7|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.5800^CK^Creatine Kinase^^2157-6^2157-6||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.5800^CK^Creatine Kinase^^2157-6^2157-6|1|100^^Y|U/L|<140|N||A^S|F|||201910281020
OBR|8|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7|1|6.0^^Y|mg/L|<7.5|N||A^S|F|||201910281020
NTE|1||This high sensitivity CRP method is sensitive to 0.3 mg/L
NTE|2||and is suitable for coronary artery risk assessment:
NTE|3||                         Less than 1.0 mg/L  low risk;
NTE|4||                         1.0 - 3.0 mg/L  intermediate risk;
NTE|5||                         Greater than 3.0 mg/L  high risk.
NTE|6||Values greater than 7.5 mg/L are significant for active
NTE|7||inflammation or infection and require follow up as
NTE|8||clinically needed. For consultation on specific patient
NTE|9||cases call your site Medical Biochemist. Interpretation
NTE|10||should be based on full history and other risk assessment
NTE|11||factors.
OBR|9|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.7020^PCT^Procalcitonin Level^^^33959-8||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|10|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|522.2490^BHCG^Beta-HCG^^^21198-7||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|522.2510^BHCG R^Beta-HCG^^21198-7^21198-7|1|< 5^^Y|IU/L|<10|N||A^S|F|||201910281020
NTE|1||Reference Intervals, (guideline only) FOR B-HCG (U/L):
NTE|2||
NTE|3||Male or non-pregnant female            Less than 10
NTE|4||Pregnant female:
NTE|5||Time after LMP:        Expected beta-HCG range(WHO 3rd IRP):
NTE|6||4th  week                               25 - 426
NTE|7||5th  week                               25 - 7340
NTE|8||6th  week                             1080 - 56500
NTE|9||10th week                            54100 - 288000
NTE|10||18th week                             8910 - 66000
NTE|11||31st week                             5310 - 27400
NTE|12||*************************NOTE*******************************
NTE|13||Occasional patients with heterophile antibodies may have
NTE|14||erroneous BHCG results. Serum BHCG should not be used for
NTE|15||routine pregnancy tests. Urine does not contain heterophile
NTE|16||antibodies and may be used where apparent discrepant results
NTE|17||are experienced.
NTE|18||Method:Beckman Access/DxI

MSH|^~\&|LAB|ARH|||201910281020||ORU^R01|4091046|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34579^LAB|00026577^2810:HC00001R^LAB^281019:HC1^34579|220.8900^INR^INR^^^6301-6||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|220.9000^INR R^INR^^6301-6^6301-6|1|1.0^^Y||0.8-1.2|N||A^S|F|||201910281020
NTE|1||INR Therapeutic Ranges:
NTE|2||    Mechanical Heart Valves 2.5 - 3.5
NTE|3||    Other indications       2.0 - 3.0
OBR|2|34579^LAB|00026577^2810:HC00001R^LAB^281019:HC1^34579|220.9600^PTT^Partial Thromboplastin Time^^14979-9^14979-9||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|220.9600^PTT^Partial Thromboplastin Time^^14979-9^14979-9|1|34^^Y|s|23-32|H||A^S|F|||201910281020
NTE|1||Note: New reference range as of Sept 18, 2019
NTE|2||
NTE|3||New Therapeutic Range for FULL DOSE Unfractionated Heparin:
NTE|4||60 - 90 secs
NTE|5||For low dose and other indications, refer to appropriate
NTE|6||nomograms.
NTE|7||
NTE|8||Note: The previous full dose unfractionated heparin
NTE|9||therapeutic range was 75-99 secs
OBR|3|34579^LAB|00026577^2810:HC00001R^LAB^281019:HC1^34579|230.0000^FIB^Quantitative Fibrinogen^^3255-7^3255-7||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|230.0000^FIB^Quantitative Fibrinogen^^3255-7^3255-7|1|3.0^^Y|g/L|1.5-4.0|N||A^S|F|||201910281020

MSH|^~\&|LAB|ARH|||201910281022||ORU^R01|4091047|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34580^LAB|00026577^2810:H00002R^LAB^281019:H2^34580|200.1000^CBC^Hematology Cell Panel^^^XCA01592-5||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|200.1300^WBC^White Blood Cell (CBC)^^12227-5^26464-8|1|25.0^^Y|x10*9/L|4.0-11.0|H||A^S|F|||201910281022
OBX|2|ST|200.1700^RBC^Red Blood Cell Count^^789-8^789-8|1|4.00^^Y|x10*12/L|3.50-5.00|N||A^S|F|||201910281022
OBX|3|ST|200.1800^HB^Hemoglobin^^718-7^718-7|1|120^^Y|g/L|115-160|N||A^S|F|||201910281022
OBX|4|ST|200.2000^HCT^Hematocrit^^4544-3^4544-3|1|0.45^^Y|L/L|0.35-0.47|N||A^S|F|||201910281022
OBX|5|ST|200.2100^MCV^Mean Corpuscular Volume^^787-2^787-2|1|90^^Y|fL|80-100|N||A^S|F|||201910281022
OBX|6|ST|200.2500^PLT^Platelet Count^^777-3^777-3|1|450^^Y|x10*9/L|150-400|H||A^S|F|||201910281022
OBX|7|ST|200.3100^NE#^Absolute Neutrophils^^751-8^26499-4|1|18.5^^Y|x10*9/L|2.0-8.0|H||A^S|F|||201910281022
OBX|8|ST|200.3300^LY#^Absolute Lymphocytes^^731-0^26474-7|1|4.0^^Y|x10*9/L|1.0-4.0|N||A^S|F|||201910281022
OBX|9|ST|200.3400^MO#^Absolute Monocytes^^742-7^26484-6|1|1.5^^Y|x10*9/L|0.1-0.8|H||A^S|F|||201910281022
OBX|10|ST|200.3500^EO#^Absolute Eosinophils^^711-2^26449-9|1|0.5^^Y|x10*9/L|<0.6|N||A^S|F|||201910281022
OBX|11|ST|200.3600^BA#^Absolute Basophils^^704-7^26444-0|1|0.5^^Y|x10*9/L|<0.2|H||A^S|F|||201910281022

MSH|^~\&|LAB|ARH|||201910281024||ORU^R01|4091048|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34582^LAB|00026577^2810:CU00001R^LAB^281019:CU1^34582|560.2500^UA^Urine Routine Macro^^^50556-0||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|560.2520^UAPP^Urine Appearance^^5767-9^5767-9|1|Sl Cloudy^^N|||N||A^S|F|||201910281024
OBX|2|ST|560.2540^UCOL^Urine Colour^^5778-6^5778-6|1|Yellow^^N|||N||A^S|F|||201910281024
OBX|3|ST|560.2600^UPH^Urine pH by Dipstick (UA)^^5803-2^5803-2|1|7.0^^N||5-7|N||A^S|F|||201910281024
OBX|4|ST|560.2700^UPROT^Urine Protein by Dipstick^^5804-0^5804-0|1|>=5.0^^N|g/L|Negative|H||A^S|F|||201910281024
OBX|5|ST|560.2800^UGLU^Urine Glucose by Dipstick^^22705-8^22705-8|1|Negative^^N|mmol/L|Negative|N||A^S|F|||201910281024
OBX|6|ST|560.2900^UKET^Urine Ketones by Dipstick^^2514-8^2514-8|1|Negative^^N||Negative|N||A^S|F|||201910281024
OBX|7|ST|560.3000^UNIT^Urine Nitrites by Dipstick^^5802-4^5802-4|1|Positive^^N||Negative|H||A^S|F|||201910281024
OBX|8|ST|560.3100^ULEUK^Urine Leukocytes by Dipstick^^27297-1^27297-1|1|25^^N|/uL|Negative|H||A^S|F|||201910281024
OBX|9|ST|560.3200^UBLD^Urine Blood by Dipstick^^5794-3^5794-3|1|Trace^^N||Negative|H||A^S|F|||201910281024
OBR|2|34582^LAB|00026577^2810:CU00001R^LAB^281019:CU1^34582|560.4100^UMIC^Urine Microscopic^^^24365-9||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||

MSH|^~\&|LAB|ARH|||201910281025||ORU^R01|4091053|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34582^LAB|00026577^2810:CU00001R^LAB^281019:CU1^34582|560.2500^UA^Urine Routine Macro^^^50556-0||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|560.2520^UAPP^Urine Appearance^^5767-9^5767-9|1|Sl Cloudy^^N|||N||A^S|F|||201910281024
OBX|2|ST|560.2540^UCOL^Urine Colour^^5778-6^5778-6|1|Yellow^^N|||N||A^S|F|||201910281024
OBX|3|ST|560.2600^UPH^Urine pH by Dipstick (UA)^^5803-2^5803-2|1|7.0^^N||5-7|N||A^S|F|||201910281024
OBX|4|ST|560.2700^UPROT^Urine Protein by Dipstick^^5804-0^5804-0|1|>=5.0^^N|g/L|Negative|H||A^S|F|||201910281024
OBX|5|ST|560.2800^UGLU^Urine Glucose by Dipstick^^22705-8^22705-8|1|Negative^^N|mmol/L|Negative|N||A^S|F|||201910281024
OBX|6|ST|560.2900^UKET^Urine Ketones by Dipstick^^2514-8^2514-8|1|Negative^^N||Negative|N||A^S|F|||201910281024
OBX|7|ST|560.3000^UNIT^Urine Nitrites by Dipstick^^5802-4^5802-4|1|Positive^^N||Negative|H||A^S|F|||201910281024
OBX|8|ST|560.3100^ULEUK^Urine Leukocytes by Dipstick^^27297-1^27297-1|1|25^^N|/uL|Negative|H||A^S|F|||201910281024
OBX|9|ST|560.3200^UBLD^Urine Blood by Dipstick^^5794-3^5794-3|1|Trace^^N||Negative|H||A^S|F|||201910281024
OBR|2|34582^LAB|00026577^2810:CU00001R^LAB^281019:CU1^34582|560.4100^UMIC^Urine Microscopic^^^24365-9||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|560.4200^UWBC^Urine WBC's   (Urine Micro)^^5821-4^5821-4|1|5-10^^N|WBC/HPF|0-5|H||A^S|F|||201910281025
OBX|2|ST|560.4300^URBC^Urine RBC's^^13945-1^13945-1|1|2-5^^N|RBC/HPF|0-5|N||A^S|F|||201910281025
OBX|3|ST|560.4400^UEPI^Urine Epithelial Cells^^5787-7^5787-7|1|Few^^N|EPI/HPF||N||A^S|F|||201910281025
OBX|4|ST|560.4500^UHYACAST^Urine Hyaline Casts^^5796-8^5796-8|1|1-2^^N|CAST/LPF|0|N||A^S|F|||201910281025
OBX|5|ST|560.4600^UGRACAST^Urine Granular Casts^^5793-5^5793-5|1|1-2^^N|CAST/LPF|0|H||A^S|F|||201910281025
OBX|6|ST|560.4900^UCRYSTAL^Urine Crystals^^5782-8^5782-8|1|Amorphous Phosphates^^N|||N||A^S|F|||201910281025
OBX|7|ST|570.0050^UVOLRAN^Urine Volume (mL)^^28009-9^28009-9|1|10^^Y|mL||N||A^S|F|||201910281025

MSH|^~\&|LAB|ARH|||201910281027||ORU^R01|4091055|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34576^LAB|00026577^2810:CG00001R^LAB^281019:CG1^34576|510.0000^BG^Blood Gas, Arterial^^^24336-0||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|510.2300^BGMODE^BG Mode of Oxygen^^3152-6^19928-1|1|Mask^^N|||N||A^S|F|||201910281027
OBX|2|ST|510.2400^BGO2FLOW^BG O2 Flow Query^^19941-4^19941-4|1|3^^N|L/min||N||A^S|F|||201910281027
OBX|3|ST|510.2500^BGPULSEOX^BG Pulse Oximeter Query^^X10176^XBC3549-5|1|80^^N|%||N||A^S|F|||201910281027
OBX|4|ST|510.2600^BGFIO2^BG Fractional Inspired O2^^19994-3^19994-3|1|0.50^^Y|||N||A^S|F|||201910281027
OBX|5|ST|510.2650^BGSPECCOM^Blood Gas Specimen Comment^^X10083^XXX-0024|1|BG COMMENT HERE^^N|||N||A^S|F|||201910281027
OBX|6|ST|510.2700^PH^pH, Arterial^^2744-1^2744-1|1|7.40^^Y||7.35-7.45|N||A^S|F|||201910281027
OBX|7|ST|510.2800^PCO2^PCO2, Arterial^^2019-8^2019-8|1|40^^Y|mmHg|35-45|N||A^S|F|||201910281027
OBX|8|ST|510.2900^PO2^PO2, Arterial^^2703-7^2703-7|1|105^^Y|mmHg|83-108|N||A^S|F|||201910281027
OBX|9|ST|510.3000^BICARBBG^Bicarbonate, Arterial^^1960-4^1960-4|1|21^^Y|mmol/L|22-26|L||A^S|F|||201910281027
OBX|10|ST|510.3200^O2SATM R^O2 Saturation, Measured^^2708-6^2708-6|1|70^^Y|%|94-98|L||A^S|F|||201910281027
OBX|11|ST|510.3250^BE^Base Excess, Arterial^^1925-7^1925-7|1|2^^Y|mmol/L|-4 to 3|N||A^S|F|||201910281027
OBX|12|ST|510.6100^AGRAD^Arterial Alveolar O2 Gradient^^19991-9^19991-9|1|202^^Y|mm Hg|10-50|H||A^S|F|||201910281027
OBX|13|ST|510.6300^PO2FIO2RATIO^PO2:FIO2 Ratio^^X10178^50984-4|1|210^^Y||>300|L||A^S|F|||201910281027

MSH|^~\&|LAB|ARH|||201910281035||ORU^R01|4091071|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|521.8005^CORAM^Cortisol AM (0600-1030)^^^14679-5||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|521.8010^CORAM R^Cortisol AM (0600-1030)^^14679-5^14679-5|1|500^^Y|nmol/L|130-600|N||A^S|F|||201910281035
OBR|2|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.0005^CEA^Carcinoembryonic Antigen^^^2039-6||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|3|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.0105^AFPTM^Alpha Fetoprotein Tumor Marker^^^53962-7||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|4|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.0705^PSA^PSA Total^^^2857-1||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|5|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.1105^CA153^CA 15-3^^^6875-9||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|6|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.1205^CA125^CA 125^^^10334-1||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||
OBR|7|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.1301^CA199^CA19-9 Tumour Marker^^^24108-3||201910280954|201910280944|||||||201910280945||||||||||LAB|I||||

MSH|^~\&|LAB|ARH|||201910281036||ORU^R01|4091072|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.1000^CP7^Chem 7 - Glu R,Urea,Crea,Lytes^^^XXX-1710||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.1900^NA^Sodium^^2951-2^2951-2|1|145^^Y|mmol/L|135-145|N||A^S|F|||201910281020
OBX|2|ST|500.2000^K^Potassium^^2823-3^2823-3|1|3.4^^Y|mmol/L|3.5-5.0|L||A^S|F|||201910281020
OBX|3|ST|500.2100^CL^Chloride^^2075-0^2075-0|1|105^^Y|mmol/L|98-108|N||A^S|F|||201910281020
OBX|4|ST|500.2200^BICARB^Bicarbonate^^1962-0^1962-0|1|25^^Y|mmol/L|20-30|N||A^S|F|||201910281020
OBX|5|ST|500.2300^GAP^Anion Gap^^33037-3^33037-3|1|15^^Y|mmol/L|3-16|N||A^S|F|||201910281020
OBX|6|ST|500.2400^UREA^Urea^^14937-7^22664-7|1|8^^Y|mmol/L|2-9|N||A^S|F|||201910281020
OBX|7|ST|500.2600^CR^Creatinine Modified Jaffe^^14682-9^14682-9|1|70^^Y|umol/L|45-90|N||A^S|F|||201910281020
OBX|8|ST|500.2700^EGFR^Glomerular Filtration Rate Est^^33914-3^33914-3|1|88^^Y|mL/min|>60|N||A^S|F|||201910281020
OBX|9|ST|500.2900^GLU^Glucose, Random^^14749-6^14749-6|1|2.0^^Y|mmol/L|3.6-7.8|LL||A^S|F|||201910281020
NTE|1||*CRITICAL VALUE
OBR|2|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.3800^CA^Calcium^^2000-8^2000-8||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.3800^CA^Calcium^^2000-8^2000-8|1|1.00^^Y|mmol/L|2.10-2.60|LL||A^S|F|||201910281020
NTE|1||*CRITICAL VALUE
OBR|3|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.3900^MG^Magnesium^^2601-3^2601-3||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.3900^MG^Magnesium^^2601-3^2601-3|1|1.1^^Y|mmol/L|0.7-1.2|N||A^S|F|||201910281020
OBR|4|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.4000^PHOS^Phosphate^^14879-1^14879-1||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.4000^PHOS^Phosphate^^14879-1^14879-1|1|1.0^^Y|mmol/L|0.8-1.5|N||A^S|F|||201910281020
OBR|5|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.4200^LFT^TP,ALB,GGT,AST,ALT,BILT,ALK^^^XXX-1710||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.4500^PROT^Protein^^2885-2^2885-2|1|90^^Y|g/L|55-80|H||A^S|F|||201910281020
OBX|2|ST|500.4600^ALB^Albumin^^1751-7^61152-5|1|70^^Y|g/L|35-50|H||A^S|F|||201910281020
OBX|3|ST|500.4700^ALK^Alkaline Phosphatase^^6768-6^6768-6|1|200^^Y|U/L|35-105|H||A^S|F|||201910281020
OBX|4|ST|500.4800^GGT^Gamma Glutamyl Transferase^^2324-2^2324-2|1|400^^Y|U/L|<31|H||A^S|F|||201910281020
OBX|5|ST|500.4900^ALT^Alanine Aminotransferase^^1742-6^1744-2|1|70^^Y|U/L|<36|H||A^S|F|||201910281020
OBX|6|ST|500.5000^AST^Aspartate Aminotransferase^^1920-8^1920-8|1|35^^Y|U/L|<36|N||A^S|F|||201910281020
OBX|7|ST|500.5200^BILT^Bilirubin, Total^^14631-6^14631-6|1|50^^Y|umol/L|2-17|H||A^S|F|||201910281020
OBR|6|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.5690^TROP^Troponin I^^^10839-9||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.5695^TROPIHS^Troponin I High Sensitivity^^89579-7^89579-7|1|5^^Y|ng/L|<18|N||A^S|F|||201910281020
NTE|1||Detectable Troponin I present. To assess the risk of acute
NTE|2||myocardial injury, consider repeat Troponin I in 3 hours to
NTE|3||evaluate the change ("delta"). If this is a follow up
NTE|4||Troponin I collected within 3-6 hours of previous:
NTE|5||Delta < 11 ng/L: Acute myocardial injury is unlikely.
NTE|6||Delta 11 - 21 ng/L: Consistent with myocardial injury, but
NTE|7||low positive predictive value for an acute event. Consider a
NTE|8||further Troponin I in another 3 hours to re-evaluate.
NTE|9||Delta >= 22 ng/L: Critical change in Troponin I. Result is
NTE|10||highly predictive for acute myocardial injury.
OBR|7|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.5800^CK^Creatine Kinase^^2157-6^2157-6||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.5800^CK^Creatine Kinase^^2157-6^2157-6|1|100^^Y|U/L|<140|N||A^S|F|||201910281020
OBR|8|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7|1|6.0^^Y|mg/L|<7.5|N||A^S|F|||201910281020
NTE|1||This high sensitivity CRP method is sensitive to 0.3 mg/L
NTE|2||and is suitable for coronary artery risk assessment:
NTE|3||                         Less than 1.0 mg/L  low risk;
NTE|4||                         1.0 - 3.0 mg/L  intermediate risk;
NTE|5||                         Greater than 3.0 mg/L  high risk.
NTE|6||Values greater than 7.5 mg/L are significant for active
NTE|7||inflammation or infection and require follow up as
NTE|8||clinically needed. For consultation on specific patient
NTE|9||cases call your site Medical Biochemist. Interpretation
NTE|10||should be based on full history and other risk assessment
NTE|11||factors.
OBR|9|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.7020^PCT^Procalcitonin Level^^^33959-8||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.7050^PCT R^Procalcitonin Level^^33959-8^33959-8|1|0.20^^Y|ug/L|0.00-0.25|N||A^S|F|||201910281036
NTE|1||Procalcitonin Level:
NTE|2||Less than or equal to 0.25: Bacterial infection is very
NTE|3||                            unlikely.
NTE|4||Greater than 0.25 to 0.50: Bacterial infection is unlikely,
NTE|5||                           repeat within 24 h as indicated.
NTE|6||Greater than 0.50 to 0.90: Bacterial infection is possible.
NTE|7||Greater than 1.00: Bacterial infection is likely. Moderate
NTE|8||                   risk for sepsis.
NTE|9||Greater than 2.00: Bacterial infection is very likely. High
NTE|10||                   risk for sepsis.
OBR|10|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|522.2490^BHCG^Beta-HCG^^^21198-7||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|522.2510^BHCG R^Beta-HCG^^21198-7^21198-7|1|< 5^^Y|IU/L|<10|N||A^S|F|||201910281020
NTE|1||Reference Intervals, (guideline only) FOR B-HCG (U/L):
NTE|2||
NTE|3||Male or non-pregnant female            Less than 10
NTE|4||Pregnant female:
NTE|5||Time after LMP:        Expected beta-HCG range(WHO 3rd IRP):
NTE|6||4th  week                               25 - 426
NTE|7||5th  week                               25 - 7340
NTE|8||6th  week                             1080 - 56500
NTE|9||10th week                            54100 - 288000
NTE|10||18th week                             8910 - 66000
NTE|11||31st week                             5310 - 27400
NTE|12||*************************NOTE*******************************
NTE|13||Occasional patients with heterophile antibodies may have
NTE|14||erroneous BHCG results. Serum BHCG should not be used for
NTE|15||routine pregnancy tests. Urine does not contain heterophile
NTE|16||antibodies and may be used where apparent discrepant results
NTE|17||are experienced.
NTE|18||Method:Beckman Access/DxI

MSH|^~\&|LAB|ARH|||201910281036||ORU^R01|4091073|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34581^LAB|00026577^2810:CP00001R^LAB^281019:CP1^34581|520.7920^FREELIGHT^Free Light Chains, Serum^^^57778-3||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|520.7925^FREEKAPPA^Free Kappa Light Chains,serum^^36916-5^36916-5|1|10.0^^Y|mg/L|3.3-19.4|N||A^S|F|||201910281036
NTE|1||Note: Effective July 19, 2019 a new method is used for
NTE|2||quantitative analysis of Free Light Chains.
OBX|2|ST|520.7930^FREELAMBDA^Free Lambda Light Chains,serum^^33944-0^33944-0|1|25.0^^Y|mg/L|5.7-26.3|N||A^S|F|||201910281036
NTE|1||Note: Effective July 19, 2019 a new method is used for
NTE|2||quantitative analysis of Free Light Chains.
OBX|3|ST|520.7935^KLRATIO^Kappa Lambda Free LC Ratio^^48378-4^48378-4|1|0.40^^Y||0.26-1.65|N||A^S|F|||201910281036

MSH|^~\&|LAB|ARH|||201910281037||ORU^R01|4091074|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|521.8005^CORAM^Cortisol AM (0600-1030)^^^14679-5||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|521.8010^CORAM R^Cortisol AM (0600-1030)^^14679-5^14679-5|1|500^^Y|nmol/L|130-600|N||A^S|F|||201910281035
OBR|2|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.0005^CEA^Carcinoembryonic Antigen^^^2039-6||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|540.0010^CEA R^Carcinoembryonic Antigen^^2039-6^2039-6|1|4.0^^Y|ug/L|<5.0|N||A^S|F|||201910281037
NTE|1||Method:Roche COBAS
OBR|3|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.0105^AFPTM^Alpha Fetoprotein Tumor Marker^^^53962-7||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|540.0110^AFPTM R^Alpha Fetoprotein Tumor Marker^^53962-7^53962-7|1|5.0^^Y|ug/L|<7.1|N||A^S|F|||201910281037
NTE|1||Method:Roche COBAS
OBR|4|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.0705^PSA^PSA Total^^^2857-1||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|540.0710^PSA R^PSA Total^^2857-1^2857-1|1|1.0^^Y|ug/L|<2.0|N||A^S|F|||201910281037
NTE|1||Note:The PSA Total reference range is based on male gender
NTE|2||Method:Roche COBAS
OBR|5|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.1105^CA153^CA 15-3^^^6875-9||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|540.1115^CA153 R^CA 15-3^^6875-9A^6875-9|1|22^^Y|kU/L|<26|N||A^S|F|||201910281037
NTE|1||Method:Roche COBAS
OBR|6|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.1205^CA125^CA 125^^^10334-1||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|540.1210^CA125 R^CA 125^^10334-1^10334-1|1|33^^Y|kU/L|<35|N||A^S|F|||201910281037
NTE|1||Method:Roche COBAS
OBR|7|34577^LAB|00026577^2810:CT00001R^LAB^281019:CT1^34577|540.1301^CA199^CA19-9 Tumour Marker^^^24108-3||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|540.1325^CA199 R^CA 19-9^^24108-3A^24108-3|1|28^^Y|kU/L|<27|H||A^S|F|||201910281037
NTE|1||Method:Roche COBAS